Latest from CannIntel
Hop latent viroid is now the costliest pathogen in commercial cannabis
How to detect it, why bleach is not enough, and the tissue-culture clean stock pipeline reshaping the industry.
The Q1 2026 MSO earnings: who's surviving compression, who isn't
Wholesale prices keep grinding lower. We read every earnings call so you don't have to.
Northern Lights: the original outdoor workhorse, profiled
Genetic background, terpene structure, yield benchmarks, and why this strain is still the default beginner outdoor pick in 2026.
Ohio adult-use sales are live: the operator economics we'd be watching
Limited license caps, transferred medical infrastructure, and the early wholesale signal.
LED vs HPS in 2026: the calculation has changed
Modern high-efficacy LEDs hit 3.0 µmol/J. Here's how that recasts the economics versus 1000W HPS.
Germany's adult-use framework, one year in: what actually changed
Cultivation associations, pharmacy access, and the European spillover effect on prices and exports.
The CannIntel legalization tracker
What growers are reading this week
Hop latent viroid is now the costliest pathogen in commercial cannabis
LED vs HPS in 2026: the calculation has changed
The germination method that consistently pops 95% of seeds
Outdoor soil prep for 2026: amend the holes, not the transplants
Trending strains right now
Strain comparisons
Best cannabis strains, by category
The cannabis glossary
The cannabis economy
The Q1 2026 MSO earnings: who's surviving compression, who isn't
Wholesale prices keep grinding lower. We read every earnings call so you don't have to.
The craft cannabis economics that the MSOs cannot match
Small-batch cultivators are gaining share in mature markets. Here's the cost structure behind why.
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.